Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDG-7500 in Healthy Adult Caucasian and Japanese Participants
NCT07456059Phase 1Completed
- Start
- Mar 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of edg-7500 in hypertrophic cardiomyopathy (HCM) (3 cohorts). Primary endpoints: Area under the concentration-time curve from time zero to the last quantifiable concentration, Area under the concentration-time curve from time zero to infinity and 3 more. Started Mar 2026; status: completed.
02
Drugs
edg-7500
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT07456059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07456059.